Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
IDEXX Laboratories, Inc.
IDXX
$669.00
Name : IDEXX Laboratories, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $53,523,140,608.00
EPSttm : 12.58
finviz dynamic chart for IDXX
IDEXX Laboratories, Inc.
$669.00
3.03%
$20.93

Float Short %

2.17

Margin Of Safety %

-12

Put/Call OI Ratio

1.14

EPS Next Q Diff

-0.02

EPS Last/This Y

2.09

EPS This/Next Y

1.5

Price

668.88

Target Price

785.75

Analyst Recom

2

Performance Q

5.07

Relative Volume

1.09

Beta

1.66

Ticker: IDXX




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-10-20IDXX643.410.830.654001
2025-10-21IDXX637.10.822.334098
2025-10-22IDXX633.710.830.394114
2025-10-23IDXX638.580.828.004150
2025-10-24IDXX640.890.832.434165
2025-10-27IDXX647.490.831.294161
2025-10-28IDXX634.360.830.234183
2025-10-29IDXX627.060.830.044200
2025-10-30IDXX628.660.792.144306
2025-10-31IDXX6310.804.364307
2025-11-03IDXX719.671.060.885340
2025-11-04IDXX721.981.050.745976
2025-11-05IDXX720.461.051.226198
2025-11-06IDXX714.391.082.236232
2025-11-07IDXX707.961.042.456308
2025-11-10IDXX709.61.041.046338
2025-11-11IDXX712.491.041.826527
2025-11-12IDXX713.741.100.656790
2025-11-13IDXX700.481.100.976844
2025-11-14IDXX689.81.092.536686
2025-11-17IDXX669.011.140.456882
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-10-20IDXX643.4111.9211.212.63
2025-10-21IDXX636.9111.8178.912.63
2025-10-22IDXX633.7811.8185.812.63
2025-10-23IDXX639.0811.8205.212.63
2025-10-24IDXX641.7911.9200.412.63
2025-10-27IDXX647.7311.9208.612.63
2025-10-28IDXX634.3611.9164.612.63
2025-10-29IDXX627.2211.9177.212.63
2025-10-30IDXX628.5412.4195.312.63
2025-10-31IDXX629.5112.4195.512.63
2025-11-03IDXX722.5812.4403.912.63
2025-11-04IDXX721.6310.7194.812.63
2025-11-05IDXX720.1410.7193.512.63
2025-11-06IDXX714.3812.0139.412.86
2025-11-07IDXX708.4512.0140.412.86
2025-11-10IDXX709.5912.0153.412.86
2025-11-11IDXX712.4712.0156.912.86
2025-11-12IDXX713.6712.0153.512.86
2025-11-13IDXX701.2412.0126.212.86
2025-11-14IDXX689.8312.0127.212.86
2025-11-17IDXX668.8812.0107.212.86
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-10-20IDXX-6.53-0.262.35
2025-10-21IDXX-6.47-0.262.35
2025-10-22IDXX-6.47-0.262.35
2025-10-23IDXX-6.47-0.262.35
2025-10-24IDXX-6.47-0.262.35
2025-10-27IDXX-6.47-0.732.24
2025-10-28IDXX-6.47-0.732.24
2025-10-29IDXX-6.47-0.732.24
2025-10-30IDXX-6.47-0.732.24
2025-10-31IDXX-6.47-0.732.24
2025-11-03IDXX-6.47-0.682.24
2025-11-04IDXX-6.47-0.682.24
2025-11-05IDXX-6.47-0.682.24
2025-11-06IDXX-6.48-0.682.25
2025-11-07IDXX-6.48-0.682.25
2025-11-10IDXX-7.42-2.552.25
2025-11-11IDXX-7.42-2.552.25
2025-11-12IDXX-7.42-2.552.17
2025-11-13IDXX-7.42-2.552.17
2025-11-14IDXX-7.29-2.552.17
2025-11-17IDXX-6.91-3.802.17
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

3.4

Avg. EPS Est. Current Quarter

2.94

Avg. EPS Est. Next Quarter

3.38

Insider Transactions

-6.91

Institutional Transactions

-3.8

Beta

1.66

Average Sales Estimate Current Quarter

1071

Average Sales Estimate Next Quarter

1096

Fair Value

587.49

Quality Score

98

Growth Score

95

Sentiment Score

80

Actual DrawDown %

9

Max Drawdown 5-Year %

-54

Target Price

785.75

P/E

53.03

Forward P/E

46.31

PEG

3.42

P/S

12.82

P/B

34.28

P/Free Cash Flow

55.44

EPS

12.61

Average EPS Est. Cur. Y​

12.86

EPS Next Y. (Est.)

14.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

24.65

Relative Volume

1.09

Return on Equity vs Sector %

38.9

Return on Equity vs Industry %

54.9

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.23

EBIT Estimation

107.2
IDEXX Laboratories, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 11000
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
stock quote shares IDXX – IDEXX Laboratories, Inc. Stock Price stock today
news today IDXX – IDEXX Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IDXX – IDEXX Laboratories, Inc. yahoo finance google finance
stock history IDXX – IDEXX Laboratories, Inc. invest stock market
stock prices IDXX premarket after hours
ticker IDXX fair value insiders trading